Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
---|
02/23/2011 | EP2287147A2 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
02/23/2011 | EP2285764A2 Monoetherified diols of diamondoids |
02/23/2011 | EP2285760A2 Cure accelerators for anaerobic curable compositions |
02/23/2011 | EP1840218B1 Process for production of optically active (S)- or (R)-beta-amino acids and optically active (R)- or (S)-beta -amino acid esters, and optically active (S)- or (R)-2-alkoxyethyl esters of beta-amino acids. |
02/23/2011 | CN101979378A Method for synthesizing chiral gamma-lactam compounds |
02/22/2011 | USRE42164 Hepatitis C inhibitor tri-peptides |
02/22/2011 | US7893297 Amorphous sodium 4-[4-chloro-2-hydroxybenzoyl)amino]butanoate |
02/22/2011 | US7893296 Method for producing an optically active β-amino acid |
02/22/2011 | US7893292 Merocyanine derivatives for cosmetic use |
02/22/2011 | US7893223 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
02/22/2011 | US7892748 Reagent for detecting an analyte |
02/22/2011 | CA2571816C Absorbent for separation of carbon dioxide |
02/22/2011 | CA2540678C Pharmaceutical compositions for prevention of overdose or abuse |
02/22/2011 | CA2350882C Transfection reagents |
02/17/2011 | WO2011019882A1 Nanostructure-beta-blocker conjugates |
02/17/2011 | WO2010123599A9 Anti-bacterial compositions and methods including targeting virulence factors of staphylococcus aureus |
02/17/2011 | WO2010118291A3 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |
02/17/2011 | US20110040094 1,3,4-trisubstituted benzenes |
02/17/2011 | US20110039933 S1p-1 receptor agonists |
02/17/2011 | US20110039852 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
02/17/2011 | US20110039819 Substituted phenoxybenzamides |
02/17/2011 | US20110039812 N-alkylcarbonyl-d-amino hydroxyalkyl ester compounds and their use |
02/17/2011 | US20110039714 Probes, Systems, and Methods for Drug Discovery |
02/16/2011 | EP2284174A1 Intermediates for the preparation of benzoxazine derivatives and process for their preparation |
02/16/2011 | EP2282982A1 Novel [f-18]-labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production |
02/16/2011 | EP2282981A1 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them |
02/16/2011 | CN101977889A Method for producing fluorine-containing acylacetic acid derivative, method for producing fluorine-containing pyrazolecarboxylic acid ester derivative, and method for producing fluorine-containing pyrazolecarboxylic acid derivative |
02/16/2011 | CN101973941A Method for preparing 4-hydroxyphenyl hydantoin |
02/16/2011 | CN101973902A Synthesis method of para aminobenzoic acid |
02/16/2011 | CN101973901A Glutamic acid continuous isoelectric crystallization method |
02/16/2011 | CN101973900A Production process for deodorizing and decolorizing fenugreek seed extract |
02/16/2011 | CN101973899A Novel production process of nanometer calcium amino acid chelate with high efficiency |
02/15/2011 | US7888532 Two-photon probe for real-time monitoring of intracellular magnesium ions, method for preparing the two-photon probe and method for real-time monitoring of intracellular magnesium ions using the two-photon probe |
02/15/2011 | US7888531 Nateglinide crystals |
02/15/2011 | US7888526 Acid addition salts of 5-aminolevulinic acid or its derivatives |
02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
02/15/2011 | CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein |
02/15/2011 | CA2456411C Stilbene derivatives and their use for binding and imaging amyloid plaques |
02/15/2011 | CA2450213C Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
02/10/2011 | US20110034726 Process Of Preparation Of Optically Active Alpha Aminoacetals |
02/10/2011 | US20110034553 Novel conjugates for treating neurodegenerative diseases and disorders |
02/10/2011 | US20110034552 Long-chain oxyaminopolyol based gelator and gel |
02/10/2011 | US20110034528 Elansolids, Novel Natural Metabolites of Flexibacter and Antibiotically Active Derivatives Thereof |
02/10/2011 | US20110033633 Method of making ligand functionalized substrates |
02/10/2011 | US20110033390 Mr imaging agent or medium compressing hyperpolarised 13c alanine and methods of imaging wherein such an imaging medium is used |
02/10/2011 | US20110033362 Process for Producing Hydrocyanic Acid |
02/09/2011 | EP2281801A1 Process for obtaining 3,3-diphenylpropylamines |
02/09/2011 | EP2280931A1 Process for converting tryptophan into kynurenine |
02/09/2011 | EP2280930A1 A novel and efficient method for the synthesis of an amino acid |
02/09/2011 | EP2280915A1 Novel ýf-18¨-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production |
02/09/2011 | CN101967126A Chiral leucine ion liquid |
02/09/2011 | CN101967106A Method for treating L-p-hydroxyphenylglycine desalting mother liquor by adopting bipolar membrane electrodialysis technology |
02/09/2011 | CN101967076A Preparation method of nitrogen dimethylated derivative of amino acid |
02/09/2011 | CN101966455A Method for preparing high-selectivity palladium-carbon catalyst by attachment and precipitation process |
02/09/2011 | CN101151256B Process for production of dibenzoxepin derivative |
02/08/2011 | US7884234 N-[4-(tert-butyl)benzyl]-N-[4 -(trifluoromethoxy)biphenyl-3-yl]oxamic Acid; Inhibitors of plasminogen activator inhibitor-1 (PAI-1); thrombogenesis, fibrogenesis, accumulation of visceral fat, cell proliferation, angiogenesis |
02/08/2011 | US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
02/08/2011 | CA2562951C Indene derivatives and process for the preparation thereof |
02/08/2011 | CA2484450C Ligands that are inhibitors of the rar receptors |
02/03/2011 | US20110028753 Stabilized Compounds Having Secondary Structure Motifs |
02/03/2011 | US20110028725 Preparation and Use of Alkylating Agents |
02/03/2011 | US20110028463 Amide compounds |
02/03/2011 | US20110027274 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
02/03/2011 | US20110027179 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy |
02/03/2011 | CA2769633A1 Crystallization method and bioavailability |
02/02/2011 | EP2279997A1 Fluorinated cyclopropane analogs of glutamic acid |
02/02/2011 | CN1972904B Preparation of pregabalin and related compounds |
02/02/2011 | CN101213193B Mono-lysine salts of azole compounds |
02/02/2011 | CN101195570B Salt amino acid of ferulic acid |
02/01/2011 | US7879907 Peroxisome Proliferator-Activated Receptor (PPAR) activators such as 3-{4-[3-(4-benzyloxy-3-methoxyphenyl)propyl]-3-butoxyphenyl}propanoic acid, used in dermatology, cosmetics, cardiovascular diseases, immunology and/or lipid metabolism |
02/01/2011 | US7879827 such as 5-amino-2-(2-Acetylamino-3-mercapto-propionyloxy)-benzoic acid, useful for the treatment of gastrointestinal disorders such as inflammatory bowel disease and irritable bowel syndrome, and for the prevention/treatment of colon cancer |
01/27/2011 | WO2011009947A1 Fluorinated cyclopropane analogs of glutamic acid |
01/27/2011 | WO2010136036A3 Calcium-sensing receptor-active compounds |
01/27/2011 | US20110022326 Quantitation Method Using Isotope Labeled Internal Standard Substance, Analysis System for Executing the Quantitation Method, and Program for the Analysis |
01/27/2011 | US20110021815 Halogenated analogues of anti-fibrotic agents |
01/27/2011 | US20110021814 Method for reducing aminoisophthalic acid bisamide related impurities in preparation of non-ionic x-ray contrast agents |
01/27/2011 | US20110021762 Method of forming oseltamivir and derivatives thereof |
01/27/2011 | US20110021761 Segmented Polymers and Their Conjugates |
01/27/2011 | US20110021628 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG |
01/27/2011 | US20110021482 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents |
01/27/2011 | US20110020324 Compound capable of binding s1p receptor and pharmaceutical use thereof |
01/27/2011 | US20110020251 Ultraviolet-Absorbing Compounds |
01/27/2011 | US20110018866 Structure of the farnesoid x receptor ligand binding domain and methods of use therefor |
01/27/2011 | CA2769053A1 Fluorinated cyclopropane analogs of glutamic acid |
01/26/2011 | EP2277870A1 Substituted benzoxa(thia)zoles |
01/26/2011 | EP2276724A2 Novel synthesis and applications of amino carboxylates |
01/26/2011 | CN101959848A Cyclohexanedimethanamine by direct amination of cyclohexanedimethanol |
01/26/2011 | CN101959847A Method for the production of aminodicarboxylic acid-N,N-diacetic acids |
01/26/2011 | CN101955547A Method for comprehensively extracting changium smyrnioide polysaccharides and amino acid |
01/26/2011 | CN101955470A Potentiators of glutamate receptors |
01/26/2011 | CN101955438A Method for preparing L-(+)-alpha-phenylglycine |
01/26/2011 | CN101955437A Glyphosate and glycine co-production technology by utilizing IDA method |
01/26/2011 | CN101954280A Copper and iron-series catalyst used for low temperature oxydehydrogenation of alkylol amine for preparing amino carboxylate |
01/26/2011 | CN101337949B Method for synthesizing beta-amido carboxylic acid ester |
01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
01/25/2011 | CA2454532C Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
01/25/2011 | CA2405853C Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts |
01/20/2011 | WO2011006763A1 A process for the preparation of fe(iii) chelates of n,n'-di(2-hydroxybenzyl)-ethylenediamine-n,n'-diacetic acid and its derivatives |
01/20/2011 | WO2011006621A1 Radiolabelling method using cycloalkyl groups |
01/20/2011 | WO2010136035A3 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |